What is Polaryx Therapeutics, Inc. 's stock-based comp?

Polaryx Therapeutics, Inc. (PLYX) reported stock-based comp of $467K in Q1 2026.

How has Polaryx Therapeutics, Inc. 's stock-based comp changed year-over-year?

Polaryx Therapeutics, Inc. 's stock-based comp decreased by 89.5% year-over-year, from $4.45M to $467K.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Polaryx Therapeutics, Inc. PLYX Stock-Based Comp

Stock-Based Comp at other companies

BioMarin PharmaceuticalsBMRN

$43.46M+15.3%

Zevra Therapeutics, Inc.ZVRA

$3.11M-0.3%

Eton Pharmaceuticals, Inc.ETON

$1.52M+26.5%

XER

Xeris Biopharma Holdings, Inc.XERS

$4.14M-6.8%

Relay Therapeutics, Inc.RLAY

$10.54M-45.5%

PVL

Palvella TherapeuticsPVLA

$3.38M+209%

Segments

By segment

See full

Lysosomal Storage Disorders$467K-89.5%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's stock-based comp?: Polaryx Therapeutics, Inc. (PLYX) reported stock-based comp of $467K in Q1 2026.
How has Polaryx Therapeutics, Inc. 's stock-based comp changed year-over-year?: Polaryx Therapeutics, Inc. 's stock-based comp decreased by 89.5% year-over-year, from $4.45M to $467K.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.